Azelby Robert

Director at ADCT; EVP & Chief Commercial Officer at Juno Therapeutics, Inc.

Sold, on record
$13.7M
Dollars the filings state
Form 4 sales
11
Latest Jun 17, 2024
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Dec 18, 2017 2017

    Sold 1,816 shares at $44.96 ($82k)

    Azelby Robert, EVP & Chief Commercial Officer

    Sold 2.5% of holdings ($3.3M position)70,832 shares left0.1x usual sizeFiling

  2. 2 Form 4 sale Juno Therapeutics, Inc.Unusual
    Jan 17, 2018 +30 days

    Sold 29,131 shares at $68.61 ($2M)

    Azelby Robert, EVP & Chief Commercial Officer

    Sold 29.1% of holdings ($6.9M position)70,832 shares left2.3x usual sizeFiling

  3. 3 Form 4 sale Juno Therapeutics, Inc.Unusual
    Jan 22, 2018 +5 days

    Sold 102,539 shares at $86.25 ($8.8M)

    Azelby Robert, EVP & Chief Commercial Officer

    Sold 59.1% of holdings ($15M position)70,832 shares left8x usual sizeFiling

  4. 4 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Feb 1, 2018 +10 days

    Sold 4,167 shares at $85.78 ($357k)

    Azelby Robert, EVP & Chief Commercial Officer

    Sold 4.1% of holdings ($8.6M position)96,471 shares left0.3x usual sizeFiling

  5. 5 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Feb 8, 2018 +7 days

    Sold 3,497 shares at $85.77 ($300k)

    Azelby Robert, EVP & Chief Commercial Officer

    Sold 3.6% of holdings ($8.3M position)93,771 shares left0.3x usual sizeFiling

  6. 6 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Feb 12, 2018 +4 days

    Sold 4,157 shares at $85.55 ($356k)

    Azelby Robert, EVP & Chief Commercial Officer

    Sold 4.4% of holdings ($8M position)89,614 shares left0.3x usual sizeFiling

  7. 7 Form 4 sale ADCTNo plan
    Jun 17, 2024 +2317 days

    Sold 6,995 shares at $2.89 ($20k)

    Azelby Robert, Director

    No 10b5-1 planSold 11.7% of holdings ($173k position)53,005 shares leftFirst sale on recordFollows a Form 144Filing

  8. 8 Form 144 notice ADCTNotice
    Jun 17, 2024 same day

    Filed to sell 6,995 shares ($20k)

    Azelby Robert, Director

    No 10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (12)

Form 144 notices and Form 4 sales by Azelby Robert
Source
Jun 17, 2024Jun 18, 2024ADCTDirectorForm 144 notice6,995$20kNoticeSEC
Jun 17, 2024Jun 18, 2024ADCTDirectorForm 4 sale6,995$20k11.7%No planSEC
Feb 12, 2018Feb 14, 2018Juno Therapeutics, Inc.EVP & Chief Commercial OfficerForm 4 sale4,157$356k4.4%Plan not statedSEC
Feb 8, 2018Feb 9, 2018Juno Therapeutics, Inc.EVP & Chief Commercial OfficerForm 4 sale3,497$300k3.6%Plan not statedSEC
Feb 1, 2018Feb 2, 2018Juno Therapeutics, Inc.EVP & Chief Commercial OfficerForm 4 sale4,167$357k4.1%Plan not statedSEC
Jan 22, 2018Jan 24, 2018Juno Therapeutics, Inc.EVP & Chief Commercial OfficerForm 4 sale102,539$8.8M59.1%UnusualSEC
Jan 17, 2018Jan 19, 2018Juno Therapeutics, Inc.EVP & Chief Commercial OfficerForm 4 sale29,131$2M29.1%UnusualSEC
Dec 18, 2017Dec 20, 2017Juno Therapeutics, Inc.EVP & Chief Commercial OfficerForm 4 sale1,816$82k2.5%Plan not statedSEC
Nov 2, 2017Nov 3, 2017Juno Therapeutics, Inc.EVP & Chief Commercial OfficerForm 4 sale6,666$366k8.3%Plan not statedSEC
Sep 13, 2017Sep 14, 2017Juno Therapeutics, Inc.EVP & Chief Commercial OfficerForm 4 sale12,850$578k25.6%UnusualSEC
Aug 29, 2017Aug 31, 2017Juno Therapeutics, Inc.EVP & Chief Commercial OfficerForm 4 sale12,869$514k20.4%Plan not statedSEC
Nov 10, 2016Nov 10, 2016Juno Therapeutics, Inc.EVP & Chief Commercial OfficerForm 4 sale12,921$312k26.6%UnusualSEC